AU778001B2 - Method of treating chronic cardiac disease - Google Patents

Method of treating chronic cardiac disease Download PDF

Info

Publication number
AU778001B2
AU778001B2 AU27341/00A AU2734100A AU778001B2 AU 778001 B2 AU778001 B2 AU 778001B2 AU 27341/00 A AU27341/00 A AU 27341/00A AU 2734100 A AU2734100 A AU 2734100A AU 778001 B2 AU778001 B2 AU 778001B2
Authority
AU
Australia
Prior art keywords
cardiac disease
chronic cardiac
bpi
leu
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU27341/00A
Other languages
English (en)
Other versions
AU2734100A (en
Inventor
Brett P. Giroir
Patrick J. Scannon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Xoma Technology Ltd USA
Original Assignee
University of Texas System
Xoma Technology Ltd USA
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, Xoma Technology Ltd USA, University of Texas at Austin filed Critical University of Texas System
Publication of AU2734100A publication Critical patent/AU2734100A/en
Application granted granted Critical
Publication of AU778001B2 publication Critical patent/AU778001B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU27341/00A 1999-01-22 2000-01-21 Method of treating chronic cardiac disease Ceased AU778001B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11673699P 1999-01-22 1999-01-22
US60/116736 1999-01-22
PCT/US2000/001515 WO2000043028A2 (en) 1999-01-22 2000-01-21 Method of treating chronic cardiac disease

Publications (2)

Publication Number Publication Date
AU2734100A AU2734100A (en) 2000-08-07
AU778001B2 true AU778001B2 (en) 2004-11-11

Family

ID=22368911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27341/00A Ceased AU778001B2 (en) 1999-01-22 2000-01-21 Method of treating chronic cardiac disease

Country Status (11)

Country Link
US (3) US6509317B1 (enExample)
EP (1) EP1143996B1 (enExample)
JP (2) JP2002535282A (enExample)
CN (1) CN1353614A (enExample)
AT (1) ATE239492T1 (enExample)
AU (1) AU778001B2 (enExample)
CA (1) CA2359681A1 (enExample)
DE (1) DE60002552T2 (enExample)
MX (1) MXPA01007031A (enExample)
NZ (1) NZ513087A (enExample)
WO (1) WO2000043028A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1339424A2 (en) 2000-12-01 2003-09-03 XOMA Technology Ltd. Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
WO2010062738A1 (en) * 2008-11-03 2010-06-03 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell 1
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
WO1997042966A1 (en) * 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646114A (en) * 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
WO1997042966A1 (en) * 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia

Also Published As

Publication number Publication date
JP2002535282A (ja) 2002-10-22
US6509317B1 (en) 2003-01-21
AU2734100A (en) 2000-08-07
DE60002552D1 (de) 2003-06-12
DE60002552T2 (de) 2004-02-26
EP1143996A2 (en) 2001-10-17
CA2359681A1 (en) 2000-07-27
EP1143996A4 (de) 2002-04-24
US20030216312A1 (en) 2003-11-20
CN1353614A (zh) 2002-06-12
WO2000043028A9 (en) 2001-09-20
JP2007126479A (ja) 2007-05-24
US20060171937A1 (en) 2006-08-03
ATE239492T1 (de) 2003-05-15
MXPA01007031A (es) 2004-08-12
WO2000043028A2 (en) 2000-07-27
EP1143996B1 (en) 2003-05-07
NZ513087A (en) 2003-02-28
WO2000043028A3 (en) 2000-11-30
US7045501B2 (en) 2006-05-16

Similar Documents

Publication Publication Date Title
AU735058B2 (en) Therapeutic uses of BPI protein products for human meningococcemia
US5912228A (en) Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US20020090368A1 (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5945399A (en) Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma
JP2007126479A (ja) 慢性心臓疾患を処置する方法
WO1998019694A1 (en) Therapeutic uses of bpi protein products in cystic fibrosis patients
US6482796B2 (en) Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
CA2367943A1 (en) Therapeutic uses of bpi protein products in bpi-deficient humans
US7041644B2 (en) Therapeutic uses of BPI protein products in BPI-deficient humans
US20030194377A1 (en) Therapeutic uses of BPI protein products in cystic fibrosis patients
WO2000018798A1 (en) Antifungal and antibacterial peptide
Scannon Therapeutic uses of BPI protein products for human meningococcemia
HK1019856B (en) Therapeutic uses of bpi protein products for human meningococcemia